GGrantIndex
Sort

34,240 grants matching atherosclerosis

Interactions of Lipoproteins with the Vascular Wall

$463,294
John Calvert Rutledge · University Of California At Davis · R01 · FY2010 · HL

ROLE OF NO AND ESTRADIOL IN AGING AND ATHEROGENESIS

$463,241
University Of California Los Angeles · R01 · FY2000 · AG

GPCR Signaling & Vascular Wall Remodeling

$463,187
Gadiparthi N Rao · University Of Tennessee Health Sci Ctr · R01 · FY2012 · HL

Early Psychosocial Intervention and Child and Parent Cardiovascular Disease Risk

$463,172
Hannah Milena Caroline Schreier · Pennsylvania State University, The · R01 · FY2019 · HL

Vascular Function, Cognition, and Brain MRI in Atherosclerotic Vascular Disease

$463,073
David J Moser · University Of Iowa · R01 · FY2011 · AG

Metabolic Rhythm Alterations as a Cause for Obesity Cardiomyopathy

$463,033
Martin Elliot Young · University Of Alabama At Birmingham · R01 · FY2019 · HL

Cardioprotective role of Humanin in aging

$463,032
Radhika Hiren Muzumdar · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG

IMMUNOCHEMICAL STRUCTURE FUNCTION OF APOLIPOPROTEIN A-I

$463,000
Scripps Research Institute · R01 · FY2002 · HL

IMMUNOCHEMICAL STRUCTURE FUNCTION OF APOLIPOPROTEIN A-I

$463,000
Scripps Research Institute · R01 · FY2003 · HL

Vascular Function, Cognition, and Brain MRI in Atherosclerotic Vascular Disease

$462,912
David J Moser · University Of Iowa · R01 · FY2009 · AG

The clinical impact of pulmonary vascular remodeling in smokers

$462,911
George R Washko · Brigham And Women'S Hospital · R01 · FY2015 · HL

Metabolic Syndrome, Lifestyle Modification and Resistance Training in HIV Disease

$462,888
Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2010 · DK

Diabetes Prevention Program Outcomes Study - Phase 2

$462,882
David A Ehrmann · University Of Chicago · U01 · FY2009 · DK

Diabetes Prevention Program Outcomes Study - Phase 2

$462,882
David A Ehrmann · University Of Chicago · U01 · FY2010 · DK

Identifying peripheral drivers of Alzheimers disease using plasma proteomics

$462,826
Keenan Walker · National Institute On Aging · ZIA · FY2021 · AG

The Contribution of Sleep and Circadian Disruption to Kynurenine Pathway Activation and Cardiometabolic Risk in Women with HIV

$462,810
Audrey French · Hektoen Institute For Medical Research · R01 · FY2021 · HL

The unexpected role of IL-23 cytokine in atherosclerosis

$462,754
Ekaterina Koltsova · Cedars-Sinai Medical Center · R01 · FY2020 · HL

Translational Research of Negative Emotions and Acute Endothelial Dysfunction

$462,638
Daichi Shimbo · Columbia University Health Sciences · R01 · FY2013 · HL

Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment

$462,522
Weidong Wang · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · DK

Structure and Function of Endothelial Fenestrae

$462,505
Radu Virgil Stan · Dartmouth College · R01 · FY2009 · HL

The Role Of SEMA4D/CD100 And Its Receptors In Platelet Biology And Thrombosis

$462,493
Lawrence Brass · University Of Pennsylvania · P50 · FY2010 · HL

Impact of Clonal Hematopoiesis on the Progression of Kidney Disease

$462,396
Cassianne Robinson-Cohen · Vanderbilt University Medical Center · R01 · FY2025 · DK

Terpene Condensation Reactions

$462,324
Charles Dale Poulter · University Of Utah · R01 · FY2006 · GM

Integrating Hypertension and Cardiovascular Disease Care into Existing HIV Service Package in Botswana (InterCARE)-Statin Sub-study

$462,277
Mosepele Mosepele · University Of Botswana · R01 · FY2025 · HL

Role of the Plasminogen Activator Protease during Pneumonic Plague

$462,195
Wyndham W. Lathem · Northwestern University At Chicago · R01 · FY2017 · AI